Report overview
Stye, also known as hordeolum, is a painful and acute infection on the upper or lower eyelid. Majority of the cases of hordeolum are due to Staphylococcus aureus followed by Staphylococcus epidermidis. All age groups can be affected, although there is a slight increase in prevalence of stye in patients aged between 30 years and 50 years. Stye can be treated with topical ointment or sometimes oral antibiotics. However, in some cases, surgeries are performed. Typically, the size of the swelling is a direct indicator of the severity of the infection. Recurrent of hordeolum is usually due to failure to eliminate the bacteria completely.
This report aims to provide a comprehensive presentation of the global market for Stye Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stye Drugs. This report contains market size and forecasts of Stye Drugs in global, including the following market information:
Global Stye Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Stye Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antibiotic Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Stye Drugs include Similasan, Bausch and Lomb, Johnson & Johnson, Novartis AG, Allergan, Daiichi Sankyo, AbbVie Inc, Sun Pharmaceutical Industries Ltd and Merck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Stye Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stye Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Stye Drugs Market Segment Percentages, by Type, 2022 (%)
Antibiotic
Ophthalmic Steroids
Global Stye Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Stye Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Stye Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Stye Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stye Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Stye Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Similasan
Bausch and Lomb
Johnson & Johnson
Novartis AG
Allergan
Daiichi Sankyo
AbbVie Inc
Sun Pharmaceutical Industries Ltd
Merck
Pfizer
XOMA
EyePoint Pharmaceuticals
Enzo Biochem Inc
TopiVert Ltd
Santen Pharmaceutical Co., Ltd
Regeneron Pharmaceuticals Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Stye Drugs, market overview.
Chapter 2: Global Stye Drugs market size in revenue.
Chapter 3: Detailed analysis of Stye Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Stye Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
